References
1. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2020;ehaa612.
2. Calkins H, Hindricks G, Cappato R, et al. 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Heart Rhythm.2017;14(10):e275-e444.
3. Verma A, Jiang CY, Betts TR, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med.2015;372(19):1812-22.
4. Kirchhof P, Calkins H. Catheter ablation in patients with persistent atrial fibrillation. Eur Heart J. 2017;38(1):20-26.
5. Gianni C, Mohanty S, Trivedi C, et al. Novel concepts and approaches in ablation of atrial fibrillation: the role of non-pulmonary vein triggers. Europace. 2018;20(10):1566-1576.
6. van Campenhout MJ, Yaksh A, Kik C, et al. Bachmann’s bundle: a key player in the development of atrial fibrillation? Circ Arrhythm Electrophysiol. 2013;6(5):1041-6.
7. Rodríguez-Mañero M, Schurmann P, Valderrábano M. Ligament and vein of Marshall: A therapeutic opportunity in atrial fibrillation. Heart Rhythm. 2016;13(2):593-601.
8. Della Bella P, Brugada J, Zeppenfeld K, et al. Epicardial ablation for ventricular tachycardia: a European multicenter study. Circ Arrhythm Electrophysiol. 2011;4(5):653-9.
9. Piorkowski C, Kronborg M, Hourdain J, et al. Endo-/Epicardial Catheter Ablation of Atrial Fibrillation: Feasibility, Outcome, and Insights Into Arrhythmia Mechanisms. Circ Arrhythm Electrophysiol. 2018;11(2):e005748.
10. Jiang R, Buch E, Gima J, et al. Feasibility of percutaneous epicardial mapping and ablation for refractory atrial fibrillation: Insights into substrate and lesion transmurality. Heart Rhythm.2019;16(8):1151-1159.
11. Yu L, Liu Q, Jiang RH, et al. Adjunctive percutaneous ablation targeting epicardial arrhythmogenic structures in patients of atrial fibrillation with recurrence after multiple procedures. J Cardiovasc Electrophysiol. 2020;31(2):401-409.
12. Hussein A, Das M, Riva S, et al. Use of Ablation Index-Guided Ablation Results in High Rates of Durable Pulmonary Vein Isolation and Freedom From Arrhythmia in Persistent Atrial Fibrillation Patients: The PRAISE Study Results. Circ Arrhythm Electrophysiol.2018;11(9):e006576.
13. Sosa E, Scanavacca M, d’Avila A, et al. A new technique to perform epicardial mapping in the electrophysiology laboratory. J Cardiovasc Electrophysiol. 1996;7(6):531-6.
14. Shah D, Haïssaguerre M, Takahashi A, et al. Differential pacing for distinguishing block from persistent conduction through an ablation line. Circulation. 2000;102(13):1517-22.
15. Lachman N, Syed FF, Habib A, et al. Correlative anatomy for the electrophysiologist, Part I: the pericardial space, oblique sinus, transverse sinus. J Cardiovasc Electrophysiol.2010;21(12):1421-6.
16. de Groot N, van der Does L, Yaksh A, et al. Direct Proof of Endo-Epicardial Asynchrony of the Atrial Wall During Atrial Fibrillation in Humans. Circ Arrhythm Electrophysiol. 2016;9(5):e003648.
17. Bayés de Luna A, Cladellas M, Oter R, et al. Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmia. Eur Heart J. 1988;9(10):1112-8.
18. Moser F, Rieger A, Pönisch C, et al. A novel ablation approach in atrial fibrillation patients undergoing fibrotic-based substrate modification: Targeting the Bachmann’s bundle? J Cardiovasc Electrophysiol. 2018;29(6):844-853.
19. Zhang J, Tang C, Zhang Y, et al. Electrophysiologic and Clinical Consequences of Left Atrial Anterior Wall Linear Ablation in Patients With Persistent Atrial Fibrillation. J Cardiovasc Electrophysiol.2015;26(9):934-943.
20. Rillig A, Tilz RR, Lin T, et al. Unexpectedly High Incidence of Stroke and Left Atrial Appendage Thrombus Formation After Electrical Isolation of the Left Atrial Appendage for the Treatment of Atrial Tachyarrhythmias. Circ Arrhythm Electrophysiol.2016;9(5):e003461.
21. Glikson M, Wolff R, Hindricks G, et al. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update.Europace. 2019:euz258.
22. Lim HS, Derval N, Komatsu Y, et al. Is ablation to termination the best strategy for ablation of persistent atrial fibrillation? Persistent atrial fibrillation is best ablated by a strategy that terminates the arrhythmia: procedural termination is associated with improved long-term outcomes. Circ Arrhythm Electrophysiol. 2015;8(4):963-71.
23. Scherr D, Khairy P, Miyazaki S, et al. Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint. Circ Arrhythm Electrophysiol. 2015;8(1):18-24.
24. Khoynezhad A, Ellenbogen KA, Al-Atassi T, et al. Hybrid Atrial Fibrillation Ablation: Current Status and a Look Ahead. Circ Arrhythm Electrophysiol. 2017;10(10):e005263.
25. DeLurgio DB, Crossen KJ, Gill J, et al. Hybrid Convergent Procedure for the Treatment of Persistent and Long Standing Persistent Atrial Fibrillation: Results of CONVERGE Clinical Trial. Circ Arrhythm Electrophysiol. 2020. doi: 10.1161/CIRCEP.120.009288.
26. Zimetbaum P. Antiarrhythmic drug therapy for atrial fibrillation.Circulation. 2012;125(2):381-9.
27. Di Biase L, Mohanty P, Mohanty S, et al. Ablation Versus Amiodarone for Treatment of Persistent Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted Device: Results From the AATAC Multicenter Randomized Trial. Circulation. 2016;133(17):1637-44.